Back
HFA Premium Access

Chronic liver disease as a predictor of one-year outcomes after cardiac resynchronization therapy implantation

Session: Heart Failure ePosters - focus on Chronic Heart Failure 6
Topic: Epidemiology, Prognosis, Outcome
Speaker: Doctor J. Correia (Viseu, PT)
Event: Heart Failure 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Joana Correia

Hospital Sao Teotonio, Viseu (Portugal)
0 follower

34 more presentations in this session

Prospective evaluation of left heart echocardiographic parameters of the EMPAG-HF patient cohort(effects of empagliflozin on diuresis and renal function in patients with acute decompensated HF)

Speaker: Mr J. Bogoviku (Jena, DE)

Access
Abstract
Slides
Like
Thumbnail

Pharmacological inhibition of Hippo pathway with XMU-MP-1 does not improve outcomes in mice with autoimmune myocarditis.

Speaker: Doctor M. Nieto (Valladolid, ES)

Access
Abstract
Slides
Like
Thumbnail

T cell and antibody response following double dose of BNT162b2 mRNA Vaccine in heart transplant recipients

Speaker: Doctor M. Vanderheyden (Aalst, BE)

Access
Abstract
Slides
Like
Thumbnail

Device-detected sleep-disordered breathing predicts implantable defibrillator therapy in patients with heart failure.

Speaker: Doctor A. Mazza (Orvieto, IT)

Access
Abstract
Slides
Like
Thumbnail

A preliminary evaluation of a novel lifestyle intervention in patients with hypertrophic cardiomyopathy

Speaker: Miss A. Fuller (Newcastle-Upon-Tyne, GB)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Heart Failure ePosters - focus on Chronic Heart Failure 6

Speakers: Doctor J. Correia, Mr J. Bogoviku, Doctor M. Nieto, Doctor M. Vanderheyden, Doctor A. Mazza...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources